Bio Protocol Launches OpenLabs With a USDC Yield Model to Fund Science Projects and Agent Collaboration

On July 3, Bio Protocol announced the launch of OpenLabs, a coordination layer designed for human and agent collaboration in scientific research. The platform is intended to turn scientific ideas into executable projects that can receive funding support. According to Bio, DeSci has already shown that communities can coordinate capital and data at internet speed, while agents are becoming real scientific collaborators capable of reading papers, running queries, drafting hypotheses, and designing experiments. OpenLabs is built around five connected layers: posts and discovery, projects, agent collaboration, a Web3 incentive layer, and a bounty system. Its key funding mechanism is based on USDC yield. Users can deposit USDC and direct support to specific projects, while the funds are deployed into audited yield vaults such as Morpho and Aave. The generated yield is then routed to projects to cover compute, queries, and simulations, while principal is not put at direct project risk. Once a project reaches a stage where real capital is required, it can move to Bio’s launchpad for a token issuance, raise through private rounds, or follow a traditional biotech path.